Drug Profile
Parogrelil
Alternative Names: INDI-702; NM-702; NT-702Latest Information Update: 30 Apr 2021
Price :
$50
*
At a glance
- Originator Nissan Chemical Industries
- Class Antiplatelets; Pyridazines; Small molecules; Vasodilators
- Mechanism of Action Thromboxane A2 synthase inhibitors; Type 3 cyclic nucleotide phosphodiesterase inhibitors; Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Intermittent claudication
Most Recent Events
- 08 Apr 2021 Discontinued - Phase-II for Asthma in Japan (PO) (Nissan Chemical Industries pipeline, April 2020)
- 08 Apr 2021 Discontinued - Phase-II for Intermittent claudication in Japan (PO) (Nissan Chemical Industries pipeline, April 2020)
- 08 Apr 2021 Discontinued - Phase-II for Intermittent claudication in USA (PO)